Sick sinus syndrome medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
**Oral vagolytic agents such as glycopyrrolate or atropine | **Oral vagolytic agents such as glycopyrrolate or atropine | ||
*Asymptomatic patients are usually monitored without therapy. | *Asymptomatic patients are usually monitored without therapy. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 22:14, 8 April 2020
Sick sinus syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sick sinus syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Sick sinus syndrome medical therapy |
Risk calculators and risk factors for Sick sinus syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The management of sick sinus syndrome depends on the underlying cause and the presenting symptoms. After correcting the reversible causes of sick sinus syndrome, it can be managed by placing an implantable pacemaker. Asymptomatic patients are usually monitored without therapy.
Medical Therapy
The management of sick sinus syndrome depends on the underlying cause and the presenting symptoms. After correcting the reversible causes of sick sinus syndrome, it can be managed by placing an implantable pacemaker.[1]
- Clinical indications of the implantable pacemaker include:
- Asymptomatic patients are followed without any treatment.
- Pharmacologic agents for the treatment of sick siuns syndrome include:
- Caffeine
- β-sympathomimetics (e.g., theophylline)
- Oral vagolytic agents such as glycopyrrolate or atropine
- Asymptomatic patients are usually monitored without therapy.